Ton A.A.C.M. Heestermans
Ton A.A.C.M. Heestermans publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Biomedical Engineering, on topics such as Acute Myocardial Infarction Research, Antiplatelet Therapy and Cardiovascular Diseases and Mechanical Circulatory Support Devices.
- World rank
- #2,464,501 of 7,710,434 ranked researchers
- Rank in Netherlands
- #52,159 of 107,149
- Works
- 16
- Citations
- 1.2k
- Citations per work
- 73.2
What does Ton A.A.C.M. Heestermans research?
Ton A.A.C.M. Heestermans's work is mostly in Medicine (69%), Engineering (12%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1168.9%
- Medicine1168.9%
- Everything else214.4%
- Physical Sciences212.5%
- Engineering212.5%
- Life Sciences14.2%
- 1Cardiology and Cardiovascular Medicine44% of their works
- 2Surgery19% of their works
- 3Biomedical Engineering8% of their works
- 4Radiology, Nuclear Medicine and Imaging6% of their works
- 5Immunology4% of their works
- 6Civil and Structural Engineering4% of their works
Research topics
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Mechanical Circulatory Support Devices
- Coronary Interventions and Diagnostics
- Cardiac Imaging and Diagnostics
- Atherosclerosis and Cardiovascular Diseases
- Atrial Fibrillation Management and Outcomes
- Hydraulic flow and structures
Which keywords describe Ton A.A.C.M. Heestermans's research?
The keywords of their largest research topics: Percutaneous Coronary Intervention, Myocardial Infarction, Guidelines, Acute Coronary Syndromes, ST-Segment Elevation, Aspirin, Atherosclerosis and Clopidogrel.
- Scale Effects
- Inflammation
- Atrial Fibrillation
- Coronary Artery Disease
- Myocardial Revascularization
- Extracorporeal Membrane Oxygenation
- Clopidogrel
- Aspirin
- Acute Coronary Syndromes
- Myocardial Infarction
- Percutaneous Coronary Intervention
- Guidelines
- ST-Segment Elevation
- Atherosclerosis
- Coronary Stents
- Left Ventricular Assist Device
- Cardiac Imaging
- Anticoagulant Therapy
- Immune Response
- Hydraulic Engineering
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Percutaneous Coronary Intervention143 topics
- Myocardial Infarction132 topics
- Guidelines122 topics
- Acute Coronary Syndromes101 topic
- ST-Segment Elevation101 topic
- Aspirin61 topic
- Atherosclerosis62 topics
- Clopidogrel61 topic
- Coronary Stents41 topic
- Extracorporeal Membrane Oxygenation41 topic
- Left Ventricular Assist Device41 topic
- Myocardial Revascularization41 topic
- Cardiac Imaging31 topic
- Coronary Artery Disease31 topic
- Anticoagulant Therapy21 topic
- Atrial Fibrillation21 topic
- Immune Response21 topic
- Inflammation21 topic
- Hydraulic Engineering11 topic
- Scale Effects11 topic
Where does Ton A.A.C.M. Heestermans work?
Ton A.A.C.M. Heestermans's main affiliation in the publication record is Isala, Netherlands.
How many publications and citations does Ton A.A.C.M. Heestermans have?
OpenAlex counts 16 works and 1,171 citations for Ton A.A.C.M. Heestermans, an h-index of 9, ranking #2,464,501 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ton A.A.C.M. Heestermans. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.